New study reveals semaglutide outperforms liraglutide in weight loss for obesity, highlighting key factors that contribute to significant weight reduction in patients. Study: One-Year Weight ...

Patients with obesity or type 2 diabetes (T2D) who stuck with their medication for a year lost more weight with semaglutide than with liraglutide, a new study reported. Researchers at the ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Liraglutide was not ...

Liraglutide is an older drug, so more people have had experience taking it. The study authors found what they describe as a disproportional risk of suicidal thoughts in people taking semaglutide ...

The researchers found 94 reports of suicidal ideation among more than 30,000 total reports associated with semaglutide and 116 reports of suicidal ideation associated with liraglutide among more ...

The analyses included 3389 adults with a body mass index of at least 30.0kg/m2 who initiated semaglutide or liraglutide for obesity or type 2 diabetes. (HealthDay News) — For patients with ...

No such link was found between liraglutide GLP-1 drugs and suicidal ideation. Other recent research, however, has found no link between semaglutide use and symptoms of depression, or suicidal ...

Semaglutide and liraglutide were associated with risk for somatic hospitalization. Patients with alcohol use disorder who used GLP-1 agonists to treat obesity or type 2 diabetes had a decreased ...

Semaglutide and liraglutide also linked to reduction in risks for SUD hospitalization, somatic hospitalizations. (HealthDay News) — Semaglutide and liraglutide are associated with a reduced risk ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is sold under the brand names Victoza and Saxenda. Liraglutide was not ...